FindTrial
Sign In

Studie naar hysteroscopische behandeling van littekendefecten na sectio bij patienten met abnormaal uterien bloedverlies.

Hystreoscopic treatment of cesarean scar defect in patients with abnormal uterine bleeding.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26833
Enrollment
22
Registered
2009-07-23
Start date
2009-01-09
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abnormal uterine bleeding cesarean scar defect hysteroscopic resection abnormaal uterien bloedverlies littekendefect na sectio hysteroscopie

Interventions

Hysteroscopic resection of cesarean scar tissue in uterus/cervix.

Sponsors

S. Veersema, gynaecoloog St Antonius Ziekenhuis, Nieuwegein L.F. van der Voet, gynaecoloog Deventer Ziekenhuis, Deventer Prof H.A.M. Brollman, gynaecoloog VU Medisch Centrum Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with a cesarean scar defect and abnormal uterine bleeding.

Exclusion criteria

Exclusion criteria: 1. Pregnancy; 2. Wish for pregnancy in future; 3. Other gynaecological problems (myoma, polyps).

Design outcomes

Primary

MeasureTime frame
Decrease in days of bloodloss/spotting (pictorial chart).—

Secondary

MeasureTime frame
1. Quality of life by SF -36 questionaire; 2. Complications; 3. Decrease in dysmenorrhoe by VAS score; 4. Satisfaction patients with therapy by questionaire.—

Contacts

Public ContactL.F. Voet, van der

Deventer ziekenhuis/St Antonius Ziekenhuis Nieuwegein N. Bolkesteinlaan 75

l.f.vandervoet@dz.nl+31 (0)570 - 53 50 52

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)